Its the only published PK study on the compound, theres no human data behind it, and it never tested sub q only IV and oral
When combined with the groundbreaking GS441524 treatment developed by CureFIP US, there is even greater potential for improved outcomes and the possibility of a true cure for FIP
B12 conversion can be a problem for people with MTR and MTRR gene mutations
Why Tablets Are Preferred Over Lyophilized Peptides Tablet formats offer several practical advantages
For people with normal B12, any weight change is usually small, inconsistent, and behaviorally driven (more activity, better appetite) rather than a direct effect of the vitamin
FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) do not contain B12 and appear as clear, colorless solutions, similar to Mounjaro and Zepbound